evenfolio

Chemicals · NSE: AETHER

Aether Industries

Price as of 12 Nov 2026
1,689.40+3.27%

Q2 FY27 earnings call · Guided by management

Call held 30 Oct 2026 · Read the filing on NSEFiling

200–250​tons per yearContract production volume at start · Agrochemical CEM contract · Q4 FY 2027Desai · p. 6
30–0​%EBITDA marginNagariya · Q&A · p. 9
100–0​USD millionBusiness with Baker Hughes · Baker Hughes · very near futureDesai · Q&A · p. 10
₹400​CrCWIP to be capitalised · Site 5 · this financial yearNagariya · Q&A · p. 14
M.Cap
₹22,423Cr
P/E
90.0×
1Y return
+127.18%
From 52W high
−6.9%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue347275+26.2%327+6.3%
EBITDA11088+25.5%103+7.5%
EBITDA margin31.8%32.0%-18 bps31.5%+34 bps
One-off items—-3———
PBTProfit before tax8974+19.2%83+6.1%
Net profit6854+26.0%63+8.4%
EPS (₹)5.114.07+25.6%4.76+7.4%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

Revenue · Baker Hughes100-— USD millionTarget of more than USD100 million business with Baker Hughes in very near future
Revenue · Semiconductor · long termRs 300-400 CrSemiconductor top line of INR300-400 crores targeted at maturity
EBITDA margin · long term30-—%EBITDA margin seen above the 30% guided; guidance kept conservative
Capex · FY27Rs 400 CrAbout INR400 crores of mainly Site 5 CWIP to be capitalised by end of this financial year
Capex · FY27Rs 350-370 CrReason given: much of the civil work on blocks is done

More figures from the call

Strata site · Guidance
3–3.5​×Asset turns · at maturity
“Yes. It will be 3, 3.5x at maturity once the -- once the production stream is matured. So we should be around 3x to 3.5x, you're right.”
Kushal Doshi · Lead Investor Relations · Q&Ap. 12
Semiconductor · Guidance
2–2.5​yearsTime to reach semiconductor run rate · next 2 to 2.5 years
“In next 2 to 2.5 years.”
Rohan Desai · Promoter and Whole Time Director · Q&Ap. 12
Agrochemical CEM contract · Guidance
50​tonsContract starting production volume
“So we're targeting 50 tons to start with, and then it would go up to 600 tons quite rapidly and then even more beyond that.”
Aman Desai · Promoter and Whole Time Director · Q&Ap. 13
LSM · Guidance
2​products per yearLSM product launches per year · every year
“Approximately 15 projects -- 12 to 15 projects on LSM side are going on in the R&D. And we plan to launch subject to our plan not being moving towards the CEM side is 2 products on LSM side every year minimum.”
Rohan Desai · Promoter and Whole Time Director · Q&Ap. 17
Semiconductor · Guidance
300–400​tonsSemiconductor sales volume · FY29
“By FY29, we are looking at 300 to 400 tons of sales on various molecules, which we have launched. And the average market price of these molecules is in the range of USD45 to USD50 a kilo.”
Rohan Desai · Promoter and Whole Time Director · Q&Ap. 19
Magnum site · Capacity
14​production blocksMagnum production blocks with line of sight · over the next 2 to 3 years
“We now do have line of sight on 14 of the 16 production blocks at Magnum. 2 are earmarked for LSM products, the remaining 12 are earmarked for CEM contracts, which we expect to commercialize over the next 2 to 3 years.”
Aman Desai · Promoter and Whole Time Directorp. 6

In short

  1. 01FY27 capex is expected at Rs 350 to 370 crore, not more.
  2. 02A new CEM contract with a global agrochemical innovator starts at Magnum in Q4 FY27.
  3. 03Management has line of sight on 14 of 16 Magnum production blocks, 12 for CEM contracts.
  4. 04Semiconductor shipments have started; top line of Rs 300 to 400 crore is targeted at maturity.
  5. 05Total Baker Hughes opportunity is put at about Rs 750 to 800 crore, covered by original Strata capex.
  6. 06EBITDA margin guidance of 30% is described as conservative.
  7. 07Working capital is around 165 days, with inventory raised for new sites.

Capex

Magnum site and R&D facility expansion on track, in places ahead of schedule

Rohan Desai · Promoter and Whole Time Director · p. 4
“In terms of looking ahead, the execution at Magnum site and the expansion of our R&D facility are on track and in the several places ahead of schedule.”

Strata site: No new block needed for new Baker Hughes products; Strata line modified

Kushal Doshi · Lead Investor Relations · Q&A · p. 11
“We do not need a new block for this, but we are remodified some of the -- one of the production lines in Site 4, which is Strata, where this product will be developed.”

Strata site: New Baker Hughes products covered by original Strata site capex

Kushal Doshi · Lead Investor Relations · Q&A · p. 12
“This will all be covered by original capex from the Strata site.”

Magnum site: Magnum civil work and equipment installation running faster than first planned

Aman Desai · Promoter and Whole Time Director · Q&A · p. 10
“We are expediting the civil construction and the plant buildups and then going towards installation of equipment in a lot of the plants much faster than what the original anticipation was.”

Magnum site: Capex to rise again when civil work for the third phase starts

Faiz Nagariya · Chief Financial Officer · Q&A · p. 14
“Yes, when we start the -- sorry, civil work for the third phase, again, the things will go.”

Capacity

Material sciences: European material science contract to expand to 5-6 products in a 1,000 tpa Magnum plant

Aman Desai · Promoter and Whole Time Director · Q&A · p. 15
“We are going to extend that to 5 to 6 products in 1 plant in Site 5 inside Magnum. That's going to be 1,000 ton per year plant.”

Magnum site: Best case: European partner could occupy 5 of 16 Magnum blocks

Aman Desai · Promoter and Whole Time Director · Q&A · p. 15
“And in a realistic best case scenario, you're looking at 5 entire plant blocks out of 16 at Site Magnum being occupied by this particular partner.”

Magnum site: Magnum: 2 plants for LSM pharma intermediate, 1 plant for semiconductor

Aman Desai · Promoter and Whole Time Director · Q&A · p. 10
“And so just to give you an idea, 2 plants are going to be an LSM model, pharmaceutical advanced intermediate. One plant is going to be a semiconductor piece that Rohan has talked about.”

Semiconductor: Semiconductor block at Magnum on track for commercial production from Q4 FY27

Rohan Desai · Promoter and Whole Time Director · p. 4
“Our new production block for this segment at the Magnum site is being equipped and is on track for commercial production from quarter 4 of financial year 2027.”

Agrochemical CEM contract: Agro CEM production at fourth Magnum block to start in Q4 FY27

Aman Desai · Promoter and Whole Time Director · p. 6
“Production will be at the fourth production block of our Magnum site and start in Q4 FY27.”

Order book

Oil and gas: Order pipeline for oil and gas products over next couple of months called extremely robust

Kushal Doshi · Lead Investor Relations · Q&A · p. 17
“But the only thing I can say is that in terms of the product pipeline, the order pipeline, which we have for these products over the next couple of months is extremely robust, and we see a good outlook for the oil and gas segment.”

Segments

CRAMS and CEM: CRAMS and CEM businesses contribute over 65% of sales

Rohan Desai · Promoter and Whole Time Director · p. 4
“Our CRAMS and CEM businesses continues to lead. Together, they now contribute over 65% of our sales.”

Oil and gas: Oil and gas is 33% of sales and expected to remain a key growth driver

Rohan Desai · Promoter and Whole Time Director · p. 4
“Oil and gas already accounts for 33% of our sales, and we expect it to remain a key growth driver.”

CRAMS: More than 65 CRAMS projects under work in R&D and pilot plant

Aman Desai · Promoter and Whole Time Director · p. 5
“Our pipeline is quite strong. We are currently working on more than 65 CRAMS projects in our R&D and pilot plant.”

CRAMS: New CRAMS engagements with auto ancillary major, mining company and oil and gas major

Aman Desai · Promoter and Whole Time Director · p. 5
“This quarter, we started new CRAMS engagements with an automotive ancillary major, a global mining company and a different oil and gas major.”

Baker Hughes: Total Baker Hughes opportunity about INR750-800 crores including another INR400 crores

Kushal Doshi · Lead Investor Relations · Q&A · p. 11
“The other -- these new products which we have started manufacturing for them is a potential market for another INR400 crores. So the total Baker opportunity does become good around INR750 crores to INR800 crores as we speak today.”

Demand

Europe: In discussions with several small and midsized European specialty chemical companies

Aman Desai · Promoter and Whole Time Director · p. 6
“but we are also in serious discussions with several small and midsized European specialty chemical companies, which is unique, I believe.”

Oil and gas: Market for new Baker Hughes products put at USD2 billion to USD2.5 billion

Rohan Desai · Promoter and Whole Time Director · Q&A · p. 10
“It's a hidden market, so we are not getting the exact numbers, but a lot of market studies have shown a range of USD2 billion to USD2.5 billion.”

Oil and gas: Oil and gas expected to attract significant investment in coming years

Rohan Desai · Promoter and Whole Time Director · p. 4
“We expect oil and gas to attract significant investments over the coming years, and Aether is well placed to benefit.”

Margins and costs

Gross margins expected to rise with shift towards CEM and CRAMS

Faiz Nagariya · Chief Financial Officer · Q&A · p. 9
“So you're right. Moving forward, the gross margins will be settling up as we move more towards to CEM and CRAMS.”

Contract manufacturing: Raw material price increases on contract manufacturing will be passed through

Faiz Nagariya · Chief Financial Officer · Q&A · p. 13
“And of course, it's a contract manufacturing. So any price increase tomorrow will be passed through, of course.”

Oil and gas: Oil and gas segment margins in line with company margins

Kushal Doshi · Lead Investor Relations · Q&A · p. 17
“The oil and gas segment, which is mostly led by the CEM contracts are in line with the company margins.”

EBITDA margins and operating leverage expected to improve in the near future

Faiz Nagariya · Chief Financial Officer · Q&A · p. 9
“Otherwise, definitely, we are looking forward to a good leap in the near future only with the EBITDA margins and the operating leverage will be better.”

Debt and working capital

Working capital cycle around 165 days, 3 days above March, due to new-site inventory

Faiz Nagariya · Chief Financial Officer · p. 9
“The working capital cycles will be improving. Currently also, it is around 165 days, which is 3 days higher than the 31st March, mainly because of the inventories which have been swelled up because of the new sites which have come up.”

Interest being capitalised on INR200 crores of loans taken

Faiz Nagariya · Chief Financial Officer · Q&A · p. 14
“And the capitalization is happening for the INR200 crores of loans, which we have already taken and the interest rate which is there.”

Inventory rise mainly due to new Milliken site and new Magnum products

Faiz Nagariya · Chief Financial Officer · Q&A · p. 18
“the increase in the raw materials or stock of inventory is mainly because of the new site, which has come up for the Milliken and also the Magnum site wherein we are launching new products.”

CEM: Inventory expected to fall once CEM production and sales are in full flow

Faiz Nagariya · Chief Financial Officer · Q&A · p. 13
“And once the production is full-fledged going on and the sales are happening, the inventory levels will come to a considerable lower level as we have always spoken about the CEM.”

Acquisitions and new business

Oil and gas: New set of oilfield chemicals for Baker Hughes commercialised and shipped in Q2 FY27

Rohan Desai · Promoter and Whole Time Director · p. 4
“We have commercialized an entire new set of oilfield industrial chemicals for Baker Hughes, which have been shipped in quarter 2 of financial year 2027, which is the current quarter under review.”

Semiconductor: First commercial shipments to semiconductor customers started from existing facilities

Rohan Desai · Promoter and Whole Time Director · p. 4
“I am pleased to share that we have started our first commercial shipments to semiconductor customers from our existing production facilities.”

Agrochemical: New CEM contract signed with a leading global agrochemical innovator for a new chemical entity

Aman Desai · Promoter and Whole Time Director · p. 6
“This quarter, we have also signed a new CEM contract, contract exclusive manufacturing contract with a leading global agrochemical innovator. It is a new chemical entity.”

Oil and gas: Announcement expected soon on a dedicated Magnum plant for an oil and gas major

Aman Desai · Promoter and Whole Time Director · p. 10
“We have one plant with an oil and gas major, which should be an announcement coming very fast, very soon in terms of dedicating an entire plant to them”

Material sciences: One material sciences plant of 1,000 tons a year under discussion with one company

Aman Desai · Promoter and Whole Time Director · p. 10
“We have 1 plant in material sciences being discussed at 1,000 tons per year with one single company.”

Management

Promoters say they will run the company for the next 30 years

Aman Desai · Promoter and Whole Time Director · Q&A · p. 7
“Rohan and I are going to run this for the next 30 years.”

R&D: 12 R&D group leaders run own programs, all with company 10+ years

Aman Desai · Promoter and Whole Time Director · Q&A · p. 7
“12 group leaders, they all run their own programs. They are all with the company for the last 10 years plus.”

Risks

Company will not take up HF, F2 and H2S chemistries

Aman Desai · Promoter and Whole Time Director · Q&A · p. 8
“For example, HF, F2, H2S. These are chemistries that we will not take up.”

Other

Agreements with leading global companies expected over coming quarters

Rohan Desai · Promoter and Whole Time Director · p. 4
“We are working on a number of exciting opportunities and expect to conclude agreements with leading global companies over the coming quarters.”

Silicones: Dow Silicones research program: immediate goal is to build and run a pilot unit

Aman Desai · Promoter and Whole Time Director · p. 5
“Our immediate goal is to design, build and operate a pilot unit.”

R&D: R&D operations moved from 24/6 to 24/7 this quarter

Aman Desai · Promoter and Whole Time Director · p. 6
“Finally, we have also moved our R&D operations from 24/6 to 24/7 this quarter.”

16 new customers added and over 20 audits completed in first half

Aman Desai · Promoter and Whole Time Director · p. 6
“In the first half, we've added 16 new customers, completed more than 20 customer and certification audits.”

Several contracts under negotiation, a number expected to conclude this financial year

Aman Desai · Promoter and Whole Time Director · p. 6
“We have also been negotiating several contracts in the recent months and expect to conclude a number of them this financial year.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools